A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community.

[1]  K. Bailey,et al.  The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects. , 2010, Journal of the American College of Cardiology.

[2]  K. Nakao,et al.  Natriuretic Peptides/cGMP/cGMP-Dependent Protein Kinase Cascades Promote Muscle Mitochondrial Biogenesis and Prevent Obesity , 2009, Diabetes.

[3]  K. Stefánsson,et al.  The T-381C SNP in BNP gene may be modestly associated with type 2 diabetes: an updated meta-analysis in 49 279 subjects. , 2009, Human molecular genetics.

[4]  J. Burnett,et al.  A new role for the natriuretic peptides: metabolic regulators of the adipocyte. , 2009, Journal of the American College of Cardiology.

[5]  T. Funahashi,et al.  Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure. , 2009, Journal of the American College of Cardiology.

[6]  D. Levy,et al.  Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure , 2009, Nature Genetics.

[7]  K. Bailey,et al.  Chronic Actions of a Novel Oral B-Type Natriuretic Peptide Conjugate in Normal Dogs and Acute Actions in Angiotensin II–Mediated Hypertension , 2008, Circulation.

[8]  W. Gower,et al.  B-Type Natriuretic Peptide Decreases Gastric Emptying and Absorption , 2008, Experimental biology and medicine.

[9]  F. Crampes,et al.  Atrial natriuretic peptide contribution to lipid mobilization and utilization during head-down bed rest in humans. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[10]  M. McCarthy,et al.  Association between the T-381C polymorphism of the brain natriuretic peptide gene and risk of type 2 diabetes in human populations. , 2007, Human molecular genetics.

[11]  D. Levy,et al.  Association of Plasma Natriuretic Peptide Levels With Metabolic Risk Factors in Ambulatory Individuals , 2007, Circulation.

[12]  T. Chrisman,et al.  Membrane guanylyl cyclase receptors: an update , 2006, Trends in Endocrinology & Metabolism.

[13]  Mark A Miller,et al.  Oral Human Brain Natriuretic Peptide Activates Cyclic Guanosine 3,5-Monophosphate and Decreases Mean Arterial Pressure , 2005, Circulation.

[14]  J. Jordan,et al.  Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans. , 2005, The Journal of clinical endocrinology and metabolism.

[15]  S. Kihara,et al.  Adiponectin-mediated modulation of hypertrophic signals in the heart , 2004, Nature Medicine.

[16]  R. Busse,et al.  Involvement of a cGMP-dependent Pathway in the Natriuretic Peptide-mediated Hormone-sensitive Lipase Phosphorylation in Human Adipocytes* , 2003, Journal of Biological Chemistry.

[17]  Douglas W Mahoney,et al.  Left atrial volume as an index of left atrial size: a population-based study. , 2003, Journal of the American College of Cardiology.

[18]  Douglas W Mahoney,et al.  Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. , 2003, JAMA.

[19]  Douglas W Mahoney,et al.  Plasma brain natriuretic peptide concentration: impact of age and gender. , 2002, Journal of the American College of Cardiology.

[20]  M. Matsuda,et al.  Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 , 2002, Nature Medicine.

[21]  R. Hammer,et al.  Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Senard,et al.  The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men. , 2001, Journal of lipid research.

[23]  H. S. Kim,et al.  Importance of quantitative genetic variations in the etiology of hypertension. , 2000, Kidney international.

[24]  E. Verspohl,et al.  Atrial natriuretic peptide (ANP)-induced inhibition of glucagon secretion: Mechanism of action in isolated rat pancreatic islets , 1996, Peptides.

[25]  K. Bailey,et al.  Determination of left ventricular mass by echocardiography in a normal population: effect of age and sex in addition to body size. , 1994, Mayo Clinic proceedings.

[26]  K. Nakao,et al.  γ-Atrial natriuretic polypeptide (γANP)-derived peptides in human plasma: Cosecretion of N-terminal γANP fragment and αANP , 1988 .

[27]  N. Seidah,et al.  NH2-terminal fragment of rat pro-atrial natriuretic factor in the circulation: Identification, radioimmunoassay and half-life , 1988, Peptides.

[28]  D. Levy,et al.  Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. , 1987, The American journal of cardiology.

[29]  P. Weidmann,et al.  Increase in Circulating Insulin Induced by Atrial Natriuretic Peptide in Normal Humans , 1986, Journal of cardiovascular pharmacology.

[30]  G. Reeder,et al.  Atrial natriuretic peptide elevation in congestive heart failure in the human. , 1986, Science.

[31]  R. Dixon,et al.  Gene structure of human cardiac hormone precursor, pronatriodilatin , 1984, Nature.

[32]  K. Kangawa,et al.  Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP) , 1984 .

[33]  A. D. de Bold,et al.  A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. , 1981, Life sciences.

[34]  J. Murray,et al.  Quantitative Angiocardiography: II. The Normal Left Atrial Volume in Man , 1968, Circulation.

[35]  R. Rodeheffer,et al.  Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. , 2006, Journal of the American College of Cardiology.

[36]  Detection.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. , 1997, Archives of internal medicine.

[37]  H. Itoh,et al.  Gamma-atrial natriuretic polypeptide (gamma ANP)-derived peptides in human plasma: cosecretion of N-terminal gamma ANP fragment and alpha ANP. , 1988, The Journal of clinical endocrinology and metabolism.

[38]  K. Kangawa,et al.  Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP). , 1984, Biochemical and biophysical research communications.